ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
Forma Therapeutics Holdings Inc

Forma Therapeutics Holdings Inc (FMTX)

20.01
0.00
(0.00%)
終了 8月1日 5:00AM
0.00
0.00
(0.00%)
取引時間後: -

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

主要統計と詳細

通貨
20.01
買値
19.98
売値
19.40
出来高
-
0.00 日の範囲 0.00
0.00 52 週間の範囲 0.00
前日終値
20.01
始値
-
時刻
最終取引時間
平均取引量 (3 か月)
-
財務取引量
-
VWAP
-

FMTX 最新ニュース

Sickle Cell Disease Association of America & Partners Launch New PSA to Boost Awareness and Understanding of the Disease

The “Believe it!” Campaign Will be Featured on TV Networks and Radio Stations Across the U.S., Driving Viewers to SCDBelieveIT.org The Sickle Cell Disease Association of America, Inc. (SCDAA...

Novo Nordisk to acquire Forma Therapeutics and expand presence in sickle cell disease and rare blood disorders

Novo Nordisk and Forma Therapeutics, Holdings Inc. (Nasdaq: FMTX) today announced that they have entered into a definitive agreement under which Novo Nordisk will acquire Forma Therapeutics for...

Forma Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update

Announced analyses from Phase I study of etavopivat in sickle cell disease indicated reduction of reported pain-related adverse events, supporting potential to reduce vaso-occlusive...

Rigel Pharmaceuticals and Forma Therapeutics Announce Licensing Agreement for Olutasidenib, a Novel Mutant IDH1 Inhibitor for the Potential Treatment of Relapsed or Refractory Acute Myeloid Leukemia

Rigel Pharmaceuticals and Forma Therapeutics Announce Licensing Agreement for Olutasidenib, a Novel Mutant IDH1 Inhibitor for the Potential Treatment of Relapsed or Refractory Acute Myeloid...

Forma Therapeutics to Report Second Quarter 2022 Financial Results and Provide Business Update on August 5, 2022

Forma Therapeutics Holdings, Inc. (Nasdaq: FMTX), a clinical-stage biopharmaceutical company focused on sickle cell disease (SCD), prostate cancer and other rare hematologic diseases and cancers...

Forma Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Forma Therapeutics Holdings, Inc. (Nasdaq: FMTX), a clinical-stage biopharmaceutical company focused on sickle cell disease, prostate cancer and other rare hematologic diseases and cancers, today...

Forma Therapeutics Announces Appointment of New Executive Team Members

Agustín Melián, M.D. to be named Executive Vice President, Head of Research and Development and Linea Aspesi to be named Senior Vice President, Chief Human Resources Officer Appointments...

Forma Therapeutics Announces Presentations at Upcoming Hematology Conferences

Updated results from the completed Phase 1 study of etavopivat in patients with sickle cell disease (SCD) Study design for the Phase 2 Gladiolus Study of etavopivat in patients with...

Forma Therapeutics to Present at the Jefferies Healthcare Conference

Forma Therapeutics Holdings, Inc. (Nasdaq: FMTX), a clinical-stage biopharmaceutical company focused on sickle cell disease, prostate cancer and other rare hematologic diseases and cancers, today...

Forma Therapeutics Highlights Etavopivat Development Expansion and Introduces New Oncology Program from Research Pipeline at Inaugural Research and Development (R&D) Day

 Expanding etavopivat development in 2022 with Phase II trial exploring transfusion burden across sickle cell disease (SCD), thalassemia and myelodysplastic syndromes (MDS) Phase 1 trial of...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
NCNCnoco noco Inc
US$ 0.28
(83.01%)
299.25M
WINTWindtree Therapeutics Inc
US$ 9.19
(61.80%)
680.7k
NUZENuZee Inc
US$ 5.915
(59.86%)
36.61M
PMECPrimech Holdings Ltd
US$ 0.8299
(57.72%)
99.11M
LSHLakeside Holding Ltd
US$ 3.70
(56.12%)
28.49M
CETUUCetus Capital Acquisition Corporation
US$ 2.60
(-62.86%)
3.1k
CETUCetus Capital Acquisition Corporation
US$ 2.22
(-62.18%)
537.32k
IMNNImunon Inc
US$ 1.33
(-59.94%)
16.24M
FGENFibroGen Inc
US$ 0.5417
(-47.41%)
16.48M
VCNXVaccinex Inc
US$ 5.09
(-36.85%)
1.06M
NVDANVIDIA Corporation
US$ 117.02
(12.81%)
473.05M
NCNCnoco noco Inc
US$ 0.28
(83.01%)
299.25M
SQQQProShares UltraPro Short QQQ
US$ 8.59
(-8.91%)
244.12M
PRSTPresto Technologies Inc
US$ 0.038406
(9.73%)
206.8M
FFIEFaraday Future Intelligent Electric Inc
US$ 0.343
(8.54%)
145.22M

最近閲覧した銘柄

Delayed Upgrade Clock